Not Yet RecruitingNot Applicable

A Study Of Phototherapy In Patients With Dementia To Improve BPSD

United States70 participantsStarted 2026-06-01

Plain-language summary

The purpose of this research is to determine whether the use of phototherapy can help reduce behavioral and psychological symptoms, including agitation in people with dementia.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients admitted on the inpatient Domitilla 3D or 4D unit. * Documented diagnosis of dementia or suspected major neurocognitive disorder. * Presence of BPSD symptoms either clinician documented in EHR or assessed through CMAI-O form * Have patient consent or have a LAR able to sign the consent on behalf of the patient. Exclusion Criteria: * Macular degeneration, blindness, or photosensitivity * Patients that do not have capacity to consent and do not have a legally authorized representative to consent on their behalf * Recent eye surgery * Bipolar disorder * Pregnancy

What they're measuring

Feasibility of 5-day phototherapy protocol

Timeframe: Day 5

Acceptability of 5-day phototherapy protocol

Timeframe: Day 5

Tolerability of 5-day phototherapy protocol

Timeframe: Day 5

Trial details

NCT IDNCT07488195

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-31

Contact for this trial

Melanie Gentry, MD

507-284-2933 gentry.melanie@mayo.edu

View on ClinicalTrials.gov More Dementia trials